What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420)
Open Access
- 18 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 20 (1), 1-14
- https://doi.org/10.1186/s12885-020-07054-2
Abstract
In principle, risk-stratification as a routine part of the NHS Breast Screening Programme (NHSBSP) should produce a better balance of benefits and harms. The main benefit is the offer of NICE-approved more frequent screening and/ or chemoprevention for women who are at increased risk, but are unaware of this. We have developed BC-Predict, to be offered to women when invited to NHSBSP which collects information on risk factors (self-reported information on family history and hormone-related factors via questionnaire; mammographic density; and in a sub-sample, Single Nucleotide Polymorphisms). BC-Predict produces risk feedback letters, inviting women at high risk (≥8% 10-year) or moderate risk (≥5 to < 8% 10-year) to have discussion of prevention and early detection options at Family History, Risk and Prevention Clinics. Despite the promise of systems such as BC-Predict, there are still too many uncertainties for a fully-powered definitive trial to be appropriate or ethical. The present research aims to identify these key uncertainties regarding the feasibility of integrating BC-Predict into the NHSBSP. Key objectives of the present research are to quantify important potential benefits and harms, and identify key drivers of the relative cost-effectiveness of embedding BC-Predict into NHSBSP. A non-randomised fully counterbalanced study design will be used, to include approximately equal numbers of women offered NHSBSP (n = 18,700) and BC-Predict (n = 18,700) from selected screening sites (n = 7). In the initial 8-month time period, women eligible for NHSBSP will be offered BC-Predict in four screening sites. Three screening sites will offer women usual NHSBSP. In the following 8-months the study sites offering usual NHSBSP switch to BC-Predict and vice versa. Key potential benefits including uptake of risk consultations, chemoprevention and additional screening will be obtained for both groups. Key potential harms such as increased anxiety will be obtained via self-report questionnaires, with embedded qualitative process analysis. A decision-analytic model-based cost-effectiveness analysis will identify the key uncertainties underpinning the relative cost-effectiveness of embedding BC-Predict into NHSBSP. We will assess the feasibility of integrating BC-Predict into the NHSBSP, and identify the main uncertainties for a definitive evaluation of the clinical and cost-effectiveness of BC-Predict. Retrospectively registered with clinicaltrials.gov (NCT04359420).Keywords
Funding Information
- Programme Grants for Applied Research (RP-PG-1214-20016)
- Manchester Biomedical Research Centre (IS-BRC-1215-20007)
- Genesis Research Trust (GA15-003)
- Prevent Breast Cancer (GA18-001)
- Breast Cancer Now (2018RP005)
This publication has 63 references indexed in Scilit:
- Women's responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study: Table 1BMJ Open, 2013
- 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010British Journal of Cancer, 2011
- Development of a self-report measure of capability wellbeing for adults: the ICECAP-AQuality of Life Research, 2011
- Estimating attendance for breast cancer screening in ethnic groups in LondonBMC Public Health, 2010
- Microcosting Quantity Data Collection MethodsMedical Care, 2009
- Developing and evaluating complex interventions: the new Medical Research Council guidanceBMJ, 2008
- Penetrance estimates for BRCA1 and BRCA2based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the familyBMC Cancer, 2008
- Using thematic analysis in psychologyQualitative Research in Psychology, 2006
- A breast cancer prediction model incorporating familial and personal risk factorsStatistics in Medicine, 2004
- Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2Science, 2003